Bird flu shots to begin in Finland (OTCQX:CSLLY)

Finland is set to become the first country to administer avian flu vaccinations, potentially as soon as next week.
“The vaccine will be offered to those aged 18 or over who are at increased risk of contracting avian influenza due to their work or other circumstances,” the Finnish Institute for Health and Welfare said in a statement to Reuters.
Finland has purchased enough doses for 10,000 people. The country has yet to see a bird flu case in humans.
The shots are being supplied by CSL Seqirus (OTCQX:CSLLY) as part of a deal to supply 40M doses to the EU.
The U.S. vaccine stockpile against bird flu currently consists of traditionally developed vaccines from GSK (GSK), Sanofi (SNY) and CSL. Messenger-RNA-based vaccine makers Moderna (MRNA), Pfizer (PFE), and CureVac (CVAC)/GSK are developing new shots.